Govt Job: For M.Pharm, M.Sc, M.Tech as Senior Research Fellow at AIIMS

The All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and post-graduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in post-graduate medical education.

Senior Research Fellow (SRF).

Applications are invited from interested candidates to fulfill the vacancy of one Senior Research Fellow (SRF) post in an ICMR-funded project, on a purely temporary basis.

Awareness of head injury while driving in patients with epilepsy (PWE): A preventive and public educational study (1-1067; 2019-2023)”

Salary: As per ICMR guidelines

Project Duration: Till Jan 2023
Age35 years

Eligibility
Essential :
1. M.Sc. (Life Sciences), MA (Social Science), and Master in Medical Social Work (MSW) degree holders. OR

2. MBBS / BDS / MVSc / M.Pharma / ME / M.Tech degree holders. With Two years of Research

Experience:
Desirable: Candidates with Medical backgrounds and previous Research Experience in Neurology will be preferred.

Interested candidates are requested to send their up-to-date curriculum vitae to aiimsneuroproject@gmail.com clearly mentioning the subject “Application for the post of SRF position for ICMR project”. Only shortlisted candidates will be called for an interview.

The last date to send curriculum vitae is 11.08.2022.

Related Posts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…

DoP may exempt 11 more drugs from public procurement rules

New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

DoP may exempt 11 more drugs from public procurement rules

DoP may exempt 11 more drugs from public procurement rules

DoP calls for proposals to set up common facilities for medical device clusters

DoP calls for proposals to set up common facilities for medical device clusters

TN Information Commission raps petitioner for abusing RTI Act with excessive requests

TN Information Commission raps petitioner for abusing RTI Act with excessive requests

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

Polymatech begins domestic manufacturing of vein finder devices

Polymatech begins domestic manufacturing of vein finder devices